An open-label clinical trial that evaluates the lung clearance index in cystic fibrosis patients ≥ 6 years of age, chronically infected with Pseudomonas aeruginosa

Update Il y a 4 ans
Reference: EUCTR2014-001204-21

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the change of LCI after 4 weeks following onset of study drug inhalation versus Baseline


Inclusion criteria

  • Chronic lung infection with Pseudomonas aeruginosa in cystic fibrosis patients

Links